↓ Skip to main content

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

Overview of attention for article published in Cancer Immunology, Immunotherapy, February 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

patent
26 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
17 Mendeley
Title
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies
Published in
Cancer Immunology, Immunotherapy, February 2006
DOI 10.1007/s00262-006-0148-4
Pubmed ID
Authors

Ignacio Azinovic, Gerald L. DeNardo, Kathleen R. Lamborn, Gary Mirick, Desiree Goldstein, Bonnie M. Bradt, Sally J. DeNardo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 29%
Student > Master 3 18%
Researcher 3 18%
Professor > Associate Professor 2 12%
Student > Doctoral Student 1 6%
Other 1 6%
Unknown 2 12%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Biochemistry, Genetics and Molecular Biology 3 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Agricultural and Biological Sciences 2 12%
Decision Sciences 1 6%
Other 0 0%
Unknown 2 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#2,525,025
of 23,245,494 outputs
Outputs from Cancer Immunology, Immunotherapy
#135
of 2,912 outputs
Outputs of similar age
#5,177
of 71,253 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#2
of 18 outputs
Altmetric has tracked 23,245,494 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,912 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 71,253 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.